- Home
- SI vs RNAC Comparison
SI vs RNAC Comparison
Compare SI & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SI | RNAC |
|---|---|---|
| Founded | 2009 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.1M | 295.3M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | SI | RNAC |
|---|---|---|
| Price | $20.99 | $8.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $20.80 | ★ $34.00 |
| AVG Volume (30 Days) | 148.5K | ★ 259.8K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,797,000.00 |
| Revenue This Year | $39.59 | N/A |
| Revenue Next Year | $31.37 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.92 | $5.60 |
| 52 Week High | $23.00 | $14.56 |
Technical Indicators
Market Signals| Indicator | SI | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 54.79 | 42.13 |
| Support Level | $12.79 | $6.04 |
| Resistance Level | $22.92 | $9.27 |
| Average True Range (ATR) | 1.58 | 0.73 |
| MACD | -0.17 | -0.29 |
| Stochastic Oscillator | 37.70 | 5.12 |
Price Performance
Historical ComparisonAbout SI Shoulder Innovations Inc.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.